Market Overview

BWXT Completes Acquisition of Sotera Health's Nordion Medical Isotope Business

Share:

BWX Technologies, Inc. (NYSE:BWXT) announced today that it has completed
the acquisition of Sotera Health's Nordion medical isotope business.

The acquisition adds approximately 150 highly trained and experienced
personnel, two specialized production centers and a uniquely licensed
infrastructure that will de-risk BWXT's entry into the medical
radioisotope market.

"We are extremely pleased to complete this strategic acquisition," said
Rex D. Geveden, BWXT's president and chief executive officer. "With
Nordion's medical isotopes business, we inherit a growing portfolio of
radioisotope products. Equally important, we will employ the Nordion
medical isotopes team, infrastructural assets and channels to market to
launch our previously announced Mo-99 product line and a number of
future radioisotope-based imaging and therapeutic products."

BWXT's medical isotopes business will be led by Tom Burnett, vice
president and general manager of BWXT ITG Canada, Inc. The business will
be included in BWXT's Nuclear Power Group segment, which is led by John
MacQuarrie, president of BWXT Canada Ltd.

Nordion's medical radioisotopes business has been a leading global
manufacturer and supplier of critical medical isotopes and
radiopharmaceuticals for research, diagnostic and therapeutic uses. Its
customers include radiopharmaceutical companies, hospitals and
radiopharmacies. In addition to supporting the new Mo-99 product line,
the medical isotope and contract manufacturing operations included in
this acquisition will continue to operate at the high level of service
their customers have come to expect with no disruption to current
operations.

BWXT now employs about 1,250 people in Ontario and British Columbia,
Canada.

Forward Looking Statements

BWXT cautions that this release contains forward-looking statements,
including, without limitation, statements relating to management's plans
and expectations for the new medical isotope production technology,
including its impact on accessibility and the Mo-99 market; expected
integration of the Company's Tc-99 generators into current radiopharmacy
processes; our ability to realize the anticipated benefits of the new
medical isotope business; future revenues from the new medical isotope
technology; market demand for Mo-99 and Tc-99m generators; timing for
Mo-99 production; and continuing Nordion operations.
These
forward-looking statements are based on management's current
expectations and involve a number of risks and uncertainties, including,
among other things, our ability to obtain the necessary regulatory
approvals, licenses and permits in a timely manner or at all; the
ability to consummate proposed transactions; competition in an
environment of rapid technological change; and the enforcement and
protection of our intellectual property rights.
If one or more of
these risks or other risks materialize, actual results may vary
materially from those expressed.
For a more complete discussion
of other risk factors that impact our business, financial condition and
results of operations, see BWXT's filings with Securities and Exchange
Commission, including our annual report on Form 10-K for the year ended
December 31, 2017 and subsequent quarterly reports on Form 10-Q.
BWXT
cautions not to place undue reliance on these forward-looking
statements, which speak only as of the date of this release, and
undertakes no obligation to update or revise any forward-looking
statement, except to the extent required by applicable law.

About BWXT

Headquartered in Lynchburg, Va., BWX Technologies, Inc. (NYSE:BWXT)
is a leading supplier of nuclear components and fuel to the U.S.
government; provides technical and management services to support the
U.S. government in the operation of complex facilities and environmental
remediation activities; and supplies precision manufactured components,
services and fuel for the commercial nuclear power industry. With
approximately 6,250 employees, BWXT has 11 major operating sites in the
U.S. and Canada. In addition, BWXT joint ventures provide management and
operations at more than a dozen U.S. Department of Energy and NASA
facilities. Follow us on Twitter @BWXTech and learn more at
www.bwxt.com.

View Comments and Join the Discussion!